Bordetella pertussis toxoid antigen (formaldehyde inactivated)

DB14388ApprovedInvestigationalVaccines

Bordetella pertussis toxoid antigen (formaldehyde inactivated) is a vaccine.

First approval
United States, 1992 · European Union, 2021
Also known as
Bordetella Pertussis Toxoid Antigen, C
Brand names
  • Hexacima
  • Vaxelis

Resolves to

What you can answer from here — as of April 02, 2025

88Clinical trialsPhase, status and sponsor resolved per trial
Sign in
86Marketed productsAcross 9 countries and 12 labellers
Sign in

Which companies are running trials of Bordetella pertussis toxoid antigen (formaldehyde inactivated), in which indications and phases, and which of those programs are still active?

Create a free account or log in to explore the full data card.

Create Account